Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 1, Open-Label, Parallel-Group, Adaptive, Single Dose Study to Evaluate the Pharmacokinetics of GS-6615 in Subjects With Normal and Impaired Hepatic Function
Brief Summary: This study will evaluate the pharmacokinetics (PK), safety, and tolerability of a single oral dose of eleclazine in participants with normal and impaired hepatic function. Participants in the healthy control group will be matched to participants with impaired hepatic function by age (± 5 years), gender, and body mass index (± 10%).